Abstract:Circulatory changes with increased blood flow and vasodilatation/vasoconstriction imbalance are an integral consequence of liver cirrhosis and portal hypertension and can affect the pulmonary circulation with the development of vascular disorders, with hepatopulmonary syndrome (HPS) being the most common. HPS is a serious pulmonary complication of progressive liver disease, resulting in a poor clinical prognosis. Vascular tone decrease, monocytic infiltration of pulmonary vessels, formation of intrapulmonary arteriovenous shunts, dysfunction of alveolar type II cells, destruction of the endothelial glycocalyx are important in the pathogenesis of HPS. Abnormalities of pulmonary capillaries lead to hypoxemia caused by a violation of the ventilation/perfusion ratio, diffusion disorders, and the development of arteriovenous anastomoses. Infiltration of the pulmonary vessels by monocytes is one of the key factors of HPS. This migration is facilitated by the intestinal microbiota translocation into the portal bloodstream with increased expression of proinflammatory cytokines (tumor necrosis factor α, interleukins 1, 6), leading to the activation of monocytes. Monocytes located in the pulmonary circulation promote the vasodilation through the activation of inducible nitric oxide (NO) synthase and thus NO production. This is also associated with endothelial dysfunction due to a decreased hepatic secretion of bone morphogenetic protein 9 and increased endothelin 1, endothelial overexpression of endothelin B receptors, and increased endothelial NO production. Proangiogenic factors such as vascular endothelial growth factor, platelet-derived growth factor, and placental growth factor play an important role in the proliferation of pulmonary capillaries. Circulation of tumor necrosis factor α, bile acids and monocyte infiltration in the pulmonary circulation lead to increased apoptosis of alveolar type II cells and decreased surfactant synthesis. Chronic inflammation in HPS disrupts the continuity of the endothelial glycocalyx layer. This article provides an overview of the current knowledge on the pathogenesis of HPS, summarizes many features of the disease based on the literature research in MEDLINE database on the PubMed platform.

Expression of Inos and Hypoxia-inducible Factor-1Α Gene Polymorphism in Hepatopulmonary Syndrome

Association Between HIF-1α Gene Polymorphisms and Lung Cancer

Expressions of IFNγ,IP-10 and CXCR3 in infection-associated hemophagocytic syndrome and their clinical significance

Mir196a2 Rs11614913 C > T Polymorphism Correlates with an Increased Risk of Hepatopulmonary Syndrome in Liver Cirrhosis: A Case-Control Study in China

Serum Soluble Vascular Endothelial Growth Factor Receptor 1 As a Potential Biomarker of Hepatopulmonary Syndrome.

Expressions of NOS and NOS Mrna in the Lung of Rats with Hepatopulmonary Syndrome

A Novel HIF2A Mutation Causes Dyslipidemia and Promotes Hepatic Lipid Accumulation

Association Between Haptoglobin Polymorphism and Acute Coronary Syndrome in Chinese

Polymorphisms of endothelial nitric oxide synthase and hypoxia-inducible factor 1 alpha genes play a role in susceptibility to coronary artery disease

Association of Genetic Polymorphisms with Chronic Obstructive Pulmonary Disease in the Hainan Population: a Case-Control Study

Proteomic Study Reveals Altered Carbamyl-Phosphate Synthetase I In Congenital Heart Disease-Associated Pulmonary Arterial Hypertension

[Expression of ET-1 Mrna in the Lung of Hepatopulmonary Syndrome Rats].

Polymorphisms of Inducible Nitric Oxide Synthase Gene, Tumor Necrosis Factor-α Gene and Susceptibility to Silicosis

Expression characteristics of hypoxia-inducible factor-1α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.

A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 ( HYAL1 ) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han Chinese

Clinical features of hepatopulmonary syndrome in cirrhotic patients

Polymorphisms of Hypoxia Inducible Factor-1α Gene and Susceptibility to Cancers

Prognostic value of hypoxia-inducible factor-1 alpha gene polymorphism in patients with heart failure with preserved ejection fraction and obstructive sleep apnea

Pathophysiological basis of hepatopulmonary syndrome

[Clinical significance of circulating hypoxia inducible factor-1α and hemeoxygenase-1 in patients with liver cirrhosis].

P1-09-08: Association of Hypoxia-Inducible Factor-1 with Breast Cancer Risk: A Meta-Analysis of Published Studies.